A

Apeloa Pharmaceutical Co Ltd
SZSE:000739

Watchlist Manager
Apeloa Pharmaceutical Co Ltd
SZSE:000739
Watchlist
Price: 15.72 CNY -3.5% Market Closed
Market Cap: 18.2B CNY
Have any thoughts about
Apeloa Pharmaceutical Co Ltd?
Write Note

EV/EBITDA
Enterprise Value to EBITDA

16.6
Current
17.1
Median
13.3
Industry
Lower than median
Higher than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
16.6
=
Enterprise Value
19.5B CNY
/
EBITDA
1.2B CNY
All Countries
Close

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
10.9
2-Years Forward
EV/EBITDA
9.5
3-Years Forward
EV/EBITDA
8.5

See Also

Discover More